7226 - 7250 of 8808 Results
Title
Year
-
OPENTitle: Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementiaJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 1Issue #: 1Start Page: 223End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/27694127.2022.2076770Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2022.2076770?needAccess=trueCitation Count: 6
-
OPENTitle: Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00445-9Best OA location URL: https://www.nature.com/articles/s41531-023-00445-9.pdfCitation Count: 17
- A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra2020OPENTitle: A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigraJournal Name: Aging CellPublisher: WileyVol: 19Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13115Citation Count: 63
-
OPENTitle: Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00336-5Best OA location URL: https://www.nature.com/articles/s41531-022-00336-5.pdfCitation Count: 20
-
OPENTitle: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET RadioligandJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 22Start Page: 4210End Page: 4219Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493Best OA location URL: https://doi.org/10.1021/acschemneuro.4c00493Citation Count: 3
-
OPENTitle: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 60Issue #: 8Start Page: 3518End Page: 3524Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01897Citation Count: 85
-
OPENTitle: CSF alpha‐synuclein aggregates by seed amplification and clinical presentation of ADJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 8Start Page: 3754End Page: 3759Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13109Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13109Citation Count: 31
-
RESTRICTEDTitle: Heterogeneous pain trajectories in persons with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 102Issue #:Start Page: 42End Page: 50Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.07.006Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.07.006Citation Count: 8
-
OPENTitle: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disordersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 6Start Page: 961End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02367-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02367-3.pdfCitation Count: 45
- Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease2018OPENTitle: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 26Issue #: 2Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13797Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6329649Citation Count: 52
-
OPENTitle: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic MiceJournal Name: NeuronPublisher: Elsevier BVVol: 88Issue #: 5Start Page: 902End Page: 909Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2015.11.018Best OA location URL: http://www.cell.com/article/S0896627315010247/pdfCitation Count: 249
- Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)2018OPENTitle: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 9Start Page: 793End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nly056Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/9/793/25507335/nly056.pdfCitation Count: 35
-
RESTRICTEDTitle: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 8Start Page: 3258End Page: 3272Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad072Best OA location URL: https://academic.oup.com/brain/article-pdf/146/8/3258/51018455/awad072.pdfCitation Count: 80
-
OPENTitle: Human upper extremity motor cortex activity shows distinct oscillatory signatures for stereotyped arm and leg movementsJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2023.1212963Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2023.1212963/pdfCitation Count: 3
-
OPENTitle: Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic NeurotransmissionJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 23Issue #: 2Start Page: 162End Page: 173Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cns.12660Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12660Citation Count: 28
-
OPENTitle: Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional ActivationJournal Name: Cell ReportsPublisher: Elsevier BVVol: 31Issue #: 13Start Page: 107843End Page: 107843Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2020.107843Best OA location URL: http://www.cell.com/article/S221112472030824X/pdfCitation Count: 334
-
RESTRICTEDTitle: Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 203Issue #: 2Start Page: 394End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.08.029Citation Count: 79
-
OPENTitle: SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1333End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27770Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7322732Citation Count: 25
-
OPENTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3589103Citation Count: 48
-
OPENTitle: Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast CancerJournal Name: Journal of OncologyPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5899728Best OA location URL: https://downloads.hindawi.com/journals/jo/2022/5899728.pdfCitation Count: 1
- In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's Disease2023OPENTitle: In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 198End Page: 198Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29315Best OA location URL: https://doi.org/10.1002/mds.29315Citation Count: 2
-
OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645.2Best OA location URL: https://doi.org/10.7554/elife.91645.2Citation Count: 32
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6261681Citation Count: 19
- Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease2018OPENTitle: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 29End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5943177Citation Count: 126
-
OPENTitle: Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00555-4Best OA location URL: https://www.nature.com/articles/s41531-023-00555-4.pdfCitation Count: 18